Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. März 2022 16:01 ET | Quelle: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer

SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
03. März 2022 16:05 ET | Quelle: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

Initiated the Phase 1b/2a PACIFIC Study, evaluating LP352 in participants with developmental and epileptic encephalopathies (DEEs)LP352 demonstrated statistically significant reduction of epileptiform...
05. Januar 2022 08:30 ET | Quelle: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
21. Januar 2021 08:30 ET | Quelle: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer

SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...
20. Januar 2021 16:30 ET | Quelle: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...